How to investigate levels of Adherence to antiretroviral ... - INRUD
How to investigate levels of Adherence to antiretroviral ... - INRUD
How to investigate levels of Adherence to antiretroviral ... - INRUD
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>How</strong> <strong>to</strong> Investigate <strong>Adherence</strong> <strong>to</strong> Antiretroviral Treatment:<br />
An Indica<strong>to</strong>r-Based Approach<br />
Q15. If the manager says a guideline is followed <strong>to</strong> start a patient on ART, then write Y<br />
and name the guideline in the next square. Otherwise write N.<br />
Q16. Ask how many days supply <strong>of</strong> ARVs are usually given <strong>to</strong> patients during their first<br />
month <strong>of</strong> treatment.<br />
Q17<br />
Ask how many days supply <strong>of</strong> ARVs are usually given <strong>to</strong> patients after their first<br />
month <strong>of</strong> treatment.<br />
Q18. Mark Y for all that apply.<br />
Q19. Mark Y for all that apply.<br />
Q20. Answer Y/N—The definition <strong>of</strong> a private space is where a conversation can be had without<br />
being overheard.<br />
Q21-22 Ask whether the programme provides child care, food for patients on ART, and has a<br />
formal system for linking patients with support <strong>of</strong> another person on ART. Answer<br />
each Y/N or S (sometimes).<br />
Q 23<br />
Ask whether the programme has formal links with the community such as churches<br />
or other organizations. Answer Y/N.<br />
Q24-25 Because there are so many different labora<strong>to</strong>ry systems the two questions <strong>to</strong> ask are:<br />
Do you have a functioning labora<strong>to</strong>ry system for measuring CD4 counts, so that<br />
results can be ready for the patient's next routine visit? Answer Y/N.<br />
Is both the test and transport for the test free for patients? Answer Y/N.<br />
The labora<strong>to</strong>ry must be working and active that day. If it is not functioning then it does not<br />
count.<br />
If both Q24 and Q25 are Y, then the indica<strong>to</strong>r <strong>of</strong> whether there is access <strong>to</strong> a labora<strong>to</strong>ry for a<br />
CD4 count will also be Y. Otherwise the indica<strong>to</strong>r will be N.<br />
Q26–28 Remember that the lists <strong>of</strong> medicines need preparing in advance. The ones given here are<br />
only suggestions.<br />
There are three columns for each <strong>of</strong> the three lists <strong>of</strong> drugs. The principles for filling in the<br />
three tables are the same.<br />
The present Y/N column<br />
For the present column, the drugs must be available and in date. It does not matter how<br />
many <strong>of</strong> them there are.<br />
For the number (#) <strong>of</strong> days in s<strong>to</strong>ck in last 90 days column<br />
48